Κλοζαπίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Κλοζαπίνη" in Greek language version.

refsWebsite

Global rank Greek rank

57nih.gov

4^th place

45doi.org

2^nd place

3^rd place

14web.archive.org

1^st place

9archive.org

6^th place

5^th place

3fda.gov

447^th place

368^th place

2drugs.com

399^th place

130^th place

2sites.google.com

626^th place

400^th place

1sussexpartnership.nhs.uk

low place

1columbia.edu

488^th place

502^nd place

1clinicalpharmacology-ip.com

low place

1nejm.org

2,374^th place

2,218^th place

1kcl.ac.uk

3,833^rd place

6,465^th place

1medscape.com

719^th place

579^th place

1rxlist.com

7,927^th place

3,123^rd place

1primarypsychiatry.com

low place

1worldcat.org

5^th place

8^th place

1books.google.com

3^rd place

6^th place

archive.org

«Findings of the Challenge To Predict Aqueous Solubility». Journal of Chemical Information and Modeling 49 (1): 1–5. 2009. doi:10.1021/ci800436c. PMID 19117422. https://archive.org/details/sim_journal-of-chemical-information-and-modeling_2009-01_49_1/page/1.
«Sexual dysfunction in schizophrenia: focus on recent evidence». Human Psychopharmacology 23 (3): 201–209. April 2008. doi:10.1002/hup.924. PMID 18338766. https://archive.org/details/sim_human-psychopharmacology_2008-04_23_3/page/201.
«Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?». The Journal of Clinical Psychiatry 74 (6): 603–13. June 2013. doi:10.4088/JCP.12r08064. PMID 23842012. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-06_74_6/page/603.
«Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy». The Journal of Clinical Psychiatry 73 (10): 1307–1312. 2012. doi:10.4088/JCP.11r06977. PMID 23140648. https://archive.org/details/sim_journal-of-clinical-psychiatry_2012-10_73_10/page/1307.
Bird, Angela M; Smith, Tawny L; Walton, Amy E (3 May 2011). «Current Treatment Strategies for Clozapine-Induced Sialorrhea». Annals of Pharmacotherapy 45 (5): 667–675. doi:10.1345/aph.1P761. PMID 21540404. https://archive.org/details/sim_annals-of-pharmacotherapy_2011-05_45_5/page/667.
«Clozapine withdrawal-emergent dystonias and dyskinesias: a case series». The Journal of Clinical Psychiatry 59 (9): 472–7. September 1998. doi:10.4088/JCP.v59n0906. PMID 9771818. https://archive.org/details/sim_journal-of-clinical-psychiatry_1998-09_59_9/page/472.
«Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents». Schizophrenia Bulletin 38 (1): 153–166. January 2012. doi:10.1093/schbul/sbq053. PMID 20494946. PMC 3245588. https://archive.org/details/sim_schizophrenia-bulletin_2012-01_38_1/page/153.
«Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia». European Journal of Clinical Pharmacology 56 (8): 585–9. November 2000. doi:10.1007/s002280000192. PMID 11151749. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_2000-11_56_8/page/585.
«Focus on clozapine». Current Medical Research and Opinion 17 (3): 223–9. 2001. doi:10.1185/0300799039117069. PMID 11900316. https://archive.org/details/sim_current-medical-research-and-opinion_2001_17_3/page/223.

books.google.com

Healy, David (2004). The Creation of Psychopharmacology. Cambridge: Harvard University Press. σελίδες 238–42. ISBN 978-0-674-01599-9.

clinicalpharmacology-ip.com

«Clinical Pharmacology». www.clinicalpharmacology-ip.com. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 27 Νοεμβρίου 2020.

columbia.edu

asp.cumc.columbia.edu

«How would you treat someone who has both schizophrenia and Parkinson's disease?». Αρχειοθετήθηκε από το πρωτότυπο στις 11 Δεκεμβρίου 2013.

doi.org

dx.doi.org

«Findings of the Challenge To Predict Aqueous Solubility». Journal of Chemical Information and Modeling 49 (1): 1–5. 2009. doi:10.1021/ci800436c. PMID 19117422. https://archive.org/details/sim_journal-of-chemical-information-and-modeling_2009-01_49_1/page/1.
«Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet 382 (9896): 951–62. September 2013. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019.
«Clozapine versus typical neuroleptic medication for schizophrenia». The Cochrane Database of Systematic Reviews (1): CD000059. January 2009. doi:10.1002/14651858.CD000059.pub2. PMID 19160174.
«Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis». The British Journal of Psychiatry 209 (5): 385–392. November 2016. doi:10.1192/bjp.bp.115.177261. PMID 27388573.
«Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine 157 (7): 498–511. October 2012. doi:10.7326/0003-4819-157-7-201210020-00525. PMID 22893011.
«The history of clozapine and its emergence in the US market: a review and analysis». History of Psychiatry 18 (1): 39–60. March 2007. doi:10.1177/0957154X07070335. PMID 17580753.
«Treatment-resistant schizophrenia--the role of clozapine». Current Medical Research and Opinion 14 (1): 1–20. 1997. doi:10.1185/03007999709113338. PMID 9524789.
«Sexual dysfunction in schizophrenia: focus on recent evidence». Human Psychopharmacology 23 (3): 201–209. April 2008. doi:10.1002/hup.924. PMID 18338766. https://archive.org/details/sim_human-psychopharmacology_2008-04_23_3/page/201.
«Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?». The Journal of Clinical Psychiatry 74 (6): 603–13. June 2013. doi:10.4088/JCP.12r08064. PMID 23842012. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-06_74_6/page/603.
«Clozapine-induced agranulocytosis. Incidence and risk factors in the United States». The New England Journal of Medicine 329 (3): 162–7. July 1993. doi:10.1056/NEJM199307153290303. PMID 8515788. Free full text with registration Αρχειοθετήθηκε 2007-10-20 στο Wayback Machine.
«Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review». Journal of Child and Adolescent Psychopharmacology 23 (8): 516–21. October 2013. doi:10.1089/cap.2013.0050. PMID 24111981.
«Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations». The Australian and New Zealand Journal of Psychiatry 51 (10): 980–989. October 2017. doi:10.1177/0004867417720516. PMID 28747065.
«The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review». Journal of Clinical Psychopharmacology 37 (5): 600–604. October 2017. doi:10.1097/JCP.0000000000000767. PMID 28817489. https://kclpure.kcl.ac.uk/portal/en/publications/the-use-of-granulocyte-colonystimulating-factor-in-clozapine-rechallenge(ca7cfadf-aa22-4c06-ae6d-a8fcce079c12).html.
«Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993–2003». Drug Safety 30 (1): 47–57. 2007. doi:10.2165/00002018-200730010-00005. PMID 17194170.
«A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls». The Australian and New Zealand Journal of Psychiatry 45 (6): 458–465. June 2011. doi:10.3109/00048674.2011.572852. PMID 21524186.
«Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study». Schizophrenia Research 141 (2–3): 173–8. November 2012. doi:10.1016/j.schres.2012.08.018. PMID 23010488.
«Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases». The Journal of Clinical Psychiatry 69 (5): 759–768. May 2008. doi:10.4088/JCP.v69n0509. PMID 18452342.
«Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study». EBioMedicine 5: 125–134. March 2016. doi:10.1016/j.ebiom.2016.02.020. PMID 27077119.
«Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy». The Journal of Clinical Psychiatry 73 (10): 1307–1312. 2012. doi:10.4088/JCP.11r06977. PMID 23140648. https://archive.org/details/sim_journal-of-clinical-psychiatry_2012-10_73_10/page/1307.
«Pharmacological treatment for antipsychotic». The Cochrane Database of Systematic Reviews 1 (1): CD011128. 24 January 2017. doi:10.1002/14651858.CD011128.pub2. PMID 28116777.
«The Porirua Protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: A pre- and post-treatment study». CNS Drugs 31 (1): 75–85. January 2017. doi:10.1007/s40263-016-0391-y. PMID 27826741.
Syed, R; Au, K; Cahill, C; Duggan, L; He, Y; Udu, V; Xia, J (16 July 2008). «Pharmacological interventions for clozapine-induced hypersalivation.». The Cochrane Database of Systematic Reviews (3): CD005579. doi:10.1002/14651858.CD005579.pub2. PMID 18646130.
Bird, Angela M; Smith, Tawny L; Walton, Amy E (3 May 2011). «Current Treatment Strategies for Clozapine-Induced Sialorrhea». Annals of Pharmacotherapy 45 (5): 667–675. doi:10.1345/aph.1P761. PMID 21540404. https://archive.org/details/sim_annals-of-pharmacotherapy_2011-05_45_5/page/667.
«Clozapine safety, 35 years later». Current Drug Safety 6 (3): 164–184. July 2011. doi:10.2174/157488611797579230. PMID 22122392.
«Nocturnal enuresis with antipsychotic medication». The British Journal of Psychiatry 200 (1): 7–9. January 2012. doi:10.1192/bjp.bp.111.095737. PMID 22215862.
«Clozapine withdrawal-emergent dystonias and dyskinesias: a case series». The Journal of Clinical Psychiatry 59 (9): 472–7. September 1998. doi:10.4088/JCP.v59n0906. PMID 9771818. https://archive.org/details/sim_journal-of-clinical-psychiatry_1998-09_59_9/page/472.
«Novel antipsychotics: comparison of weight gain liabilities». The Journal of Clinical Psychiatry 60 (6): 358–63. June 1999. doi:10.4088/JCP.v60n0602. PMID 10401912.
«Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles». Molecular Psychiatry 13 (1): 27–35. January 2008. doi:10.1038/sj.mp.4002066. PMID 17848919.
«Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents». Schizophrenia Bulletin 38 (1): 153–166. January 2012. doi:10.1093/schbul/sbq053. PMID 20494946. PMC 3245588. https://archive.org/details/sim_schizophrenia-bulletin_2012-01_38_1/page/153.
«Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence». Clinical Pharmacokinetics 33 (6): 454–71. December 1997. doi:10.2165/00003088-199733060-00004. PMID 9435993.
«Carbamazepine-induced changes in plasma levels of neuroleptics». Pharmacopsychiatry 28 (1): 26–8. January 1995. doi:10.1055/s-2007-979584. PMID 7746842.
«Interactions between antiepileptic and antipsychotic drugs». Drug Safety 29 (2): 95–118. 2006. doi:10.2165/00002018-200629020-00001. PMID 16454538.
«Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service». Therapeutic Drug Monitoring 16 (4): 368–74. August 1994. doi:10.1097/00007691-199408000-00006. PMID 7974626.
«Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review». Journal of Psychiatric Practice 14 (5): 265–70. September 2008. doi:10.1097/01.pra.0000336753.11943.7c. PMID 18832957.
«Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia». European Journal of Clinical Pharmacology 56 (8): 585–9. November 2000. doi:10.1007/s002280000192. PMID 11151749. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_2000-11_56_8/page/585.
«Focus on clozapine». Current Medical Research and Opinion 17 (3): 223–9. 2001. doi:10.1185/0300799039117069. PMID 11900316. https://archive.org/details/sim_current-medical-research-and-opinion_2001_17_3/page/223.
«Evidence that clozapine directly interacts on the GABAB receptor». NeuroReport 22 (13): 637–41. September 2011. doi:10.1097/WNR.0b013e328349739b. PMID 21753741.
«Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice». Journal of Neurochemistry 97 (4): 979–91. May 2006. doi:10.1111/j.1471-4159.2006.03806.x. PMID 16606363.
«The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice». British Journal of Pharmacology 163 (5): 1034–47. July 2011. doi:10.1111/j.1476-5381.2011.01301.x. PMID 21371011.
«Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes». British Journal of Pharmacology 165 (5): 1543–55. March 2012. doi:10.1111/j.1476-5381.2011.01638.x. PMID 21880034.
«Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex». Neuropsychopharmacology 36 (6): 1260–74. May 2011. doi:10.1038/npp.2011.12. PMID 21326193.
DiSanto, Anthony R.; Golden, Gil (2009-08-01). «Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg» (στα αγγλικά). Clinical Drug Investigation 29 (8): 539–549. doi:10.2165/00044011-200929080-00004. ISSN 1179-1918. PMID 19591515.
«Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients». Journal of Clinical Psychopharmacology 24 (1): 70–8. February 2004. doi:10.1097/01.jcp.0000106221.36344.4d. PMID 14709950.
«Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics». The Journal of Clinical Psychiatry 60 (1): 36–40. January 1999. doi:10.4088/JCP.v60n0108. PMID 10074876.
«Letter: Clozapine and agranulocytosis». Lancet 2 (7936): 657. October 1975. doi:10.1016/s0140-6736(75)90135-x. PMID 52022.

drugs.com

«Clozapine». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 1 Δεκεμβρίου 2015.
«Clozapine International Brands». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαρτίου 2017. Ανακτήθηκε στις 28 Φεβρουαρίου 2017.

fda.gov

accessdata.fda.gov

«Supplemental NDA Approval Letter for Clozaril, NDA 19-758 / S-047» (PDF). United States Food and Drug Administration. 18 Δεκεμβρίου 2002. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 8 Νοεμβρίου 2013. Ανακτήθηκε στις 23 Νοεμβρίου 2012.
«Letter to Novartis Pharmaceuticals Corporation» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 11 Μαΐου 2011. Ανακτήθηκε στις 20 Σεπτεμβρίου 2009.

fda.gov

«Clozaril, Fazaclo ODT, Versacloz (clozapine): Drug Safety Communication - FDA Strengthens Warning That Untreated Constipation Can Lead to Serious Bowel Problems». FDA (στα Αγγλικά). 28 Ιανουαρίου 2020. Ανακτήθηκε στις 30 Ιανουαρίου 2020.

kcl.ac.uk

kclpure.kcl.ac.uk

«The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review». Journal of Clinical Psychopharmacology 37 (5): 600–604. October 2017. doi:10.1097/JCP.0000000000000767. PMID 28817489. https://kclpure.kcl.ac.uk/portal/en/publications/the-use-of-granulocyte-colonystimulating-factor-in-clozapine-rechallenge(ca7cfadf-aa22-4c06-ae6d-a8fcce079c12).html.

medscape.com

«Treatment of Clozapine-Induced Sialorrhea». Αρχειοθετήθηκε από το πρωτότυπο στις 9 Φεβρουαρίου 2012. Ανακτήθηκε στις 8 Φεβρουαρίου 2010.

nejm.org

content.nejm.org

«Clozapine-induced agranulocytosis. Incidence and risk factors in the United States». The New England Journal of Medicine 329 (3): 162–7. July 1993. doi:10.1056/NEJM199307153290303. PMID 8515788. Free full text with registration Αρχειοθετήθηκε 2007-10-20 στο Wayback Machine.

nih.gov

ncbi.nlm.nih.gov

«Findings of the Challenge To Predict Aqueous Solubility». Journal of Chemical Information and Modeling 49 (1): 1–5. 2009. doi:10.1021/ci800436c. PMID 19117422. https://archive.org/details/sim_journal-of-chemical-information-and-modeling_2009-01_49_1/page/1.
«Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet 382 (9896): 951–62. September 2013. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019.
«Clozapine versus typical neuroleptic medication for schizophrenia». The Cochrane Database of Systematic Reviews (1): CD000059. January 2009. doi:10.1002/14651858.CD000059.pub2. PMID 19160174.
«Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis». The British Journal of Psychiatry 209 (5): 385–392. November 2016. doi:10.1192/bjp.bp.115.177261. PMID 27388573.
«Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine 157 (7): 498–511. October 2012. doi:10.7326/0003-4819-157-7-201210020-00525. PMID 22893011.
Haidary, HA; Padhy, RK (January 2019). Clozapine. PMID 30571020.
«The history of clozapine and its emergence in the US market: a review and analysis». History of Psychiatry 18 (1): 39–60. March 2007. doi:10.1177/0957154X07070335. PMID 17580753.
«Treatment-resistant schizophrenia--the role of clozapine». Current Medical Research and Opinion 14 (1): 1–20. 1997. doi:10.1185/03007999709113338. PMID 9524789.
«Sexual dysfunction in schizophrenia: focus on recent evidence». Human Psychopharmacology 23 (3): 201–209. April 2008. doi:10.1002/hup.924. PMID 18338766. https://archive.org/details/sim_human-psychopharmacology_2008-04_23_3/page/201.
«Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?». The Journal of Clinical Psychiatry 74 (6): 603–13. June 2013. doi:10.4088/JCP.12r08064. PMID 23842012. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-06_74_6/page/603.
«Clozapine-induced agranulocytosis. Incidence and risk factors in the United States». The New England Journal of Medicine 329 (3): 162–7. July 1993. doi:10.1056/NEJM199307153290303. PMID 8515788. Free full text with registration Αρχειοθετήθηκε 2007-10-20 στο Wayback Machine.
«Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review». Journal of Child and Adolescent Psychopharmacology 23 (8): 516–21. October 2013. doi:10.1089/cap.2013.0050. PMID 24111981.
«Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations». The Australian and New Zealand Journal of Psychiatry 51 (10): 980–989. October 2017. doi:10.1177/0004867417720516. PMID 28747065.
«The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review». Journal of Clinical Psychopharmacology 37 (5): 600–604. October 2017. doi:10.1097/JCP.0000000000000767. PMID 28817489. https://kclpure.kcl.ac.uk/portal/en/publications/the-use-of-granulocyte-colonystimulating-factor-in-clozapine-rechallenge(ca7cfadf-aa22-4c06-ae6d-a8fcce079c12).html.
«Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993–2003». Drug Safety 30 (1): 47–57. 2007. doi:10.2165/00002018-200730010-00005. PMID 17194170.
«A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls». The Australian and New Zealand Journal of Psychiatry 45 (6): 458–465. June 2011. doi:10.3109/00048674.2011.572852. PMID 21524186.
«Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study». Schizophrenia Research 141 (2–3): 173–8. November 2012. doi:10.1016/j.schres.2012.08.018. PMID 23010488.
«Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases». The Journal of Clinical Psychiatry 69 (5): 759–768. May 2008. doi:10.4088/JCP.v69n0509. PMID 18452342.
«Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study». EBioMedicine 5: 125–134. March 2016. doi:10.1016/j.ebiom.2016.02.020. PMID 27077119.
«Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy». The Journal of Clinical Psychiatry 73 (10): 1307–1312. 2012. doi:10.4088/JCP.11r06977. PMID 23140648. https://archive.org/details/sim_journal-of-clinical-psychiatry_2012-10_73_10/page/1307.
«Pharmacological treatment for antipsychotic». The Cochrane Database of Systematic Reviews 1 (1): CD011128. 24 January 2017. doi:10.1002/14651858.CD011128.pub2. PMID 28116777.
«The Porirua Protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: A pre- and post-treatment study». CNS Drugs 31 (1): 75–85. January 2017. doi:10.1007/s40263-016-0391-y. PMID 27826741.
Syed, R; Au, K; Cahill, C; Duggan, L; He, Y; Udu, V; Xia, J (16 July 2008). «Pharmacological interventions for clozapine-induced hypersalivation.». The Cochrane Database of Systematic Reviews (3): CD005579. doi:10.1002/14651858.CD005579.pub2. PMID 18646130.
Bird, Angela M; Smith, Tawny L; Walton, Amy E (3 May 2011). «Current Treatment Strategies for Clozapine-Induced Sialorrhea». Annals of Pharmacotherapy 45 (5): 667–675. doi:10.1345/aph.1P761. PMID 21540404. https://archive.org/details/sim_annals-of-pharmacotherapy_2011-05_45_5/page/667.
«Clozapine safety, 35 years later». Current Drug Safety 6 (3): 164–184. July 2011. doi:10.2174/157488611797579230. PMID 22122392.
«Nocturnal enuresis with antipsychotic medication». The British Journal of Psychiatry 200 (1): 7–9. January 2012. doi:10.1192/bjp.bp.111.095737. PMID 22215862.
«Clozapine withdrawal-emergent dystonias and dyskinesias: a case series». The Journal of Clinical Psychiatry 59 (9): 472–7. September 1998. doi:10.4088/JCP.v59n0906. PMID 9771818. https://archive.org/details/sim_journal-of-clinical-psychiatry_1998-09_59_9/page/472.
«[Clozapine withdrawal. A review]». Psychiatria Polska 33 (1): 51–67. 1999. PMID 10786215.
«Novel antipsychotics: comparison of weight gain liabilities». The Journal of Clinical Psychiatry 60 (6): 358–63. June 1999. doi:10.4088/JCP.v60n0602. PMID 10401912.
«Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles». Molecular Psychiatry 13 (1): 27–35. January 2008. doi:10.1038/sj.mp.4002066. PMID 17848919.
«Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents». Schizophrenia Bulletin 38 (1): 153–166. January 2012. doi:10.1093/schbul/sbq053. PMID 20494946. PMC 3245588. https://archive.org/details/sim_schizophrenia-bulletin_2012-01_38_1/page/153.
Keck, PE Jr.; McElroy, SL (2002). «Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications». J Clin Psychiatry 63 (Suppl 4): 3–11. PMID 11913673.
«Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence». Clinical Pharmacokinetics 33 (6): 454–71. December 1997. doi:10.2165/00003088-199733060-00004. PMID 9435993.
«Carbamazepine-induced changes in plasma levels of neuroleptics». Pharmacopsychiatry 28 (1): 26–8. January 1995. doi:10.1055/s-2007-979584. PMID 7746842.
«Interactions between antiepileptic and antipsychotic drugs». Drug Safety 29 (2): 95–118. 2006. doi:10.2165/00002018-200629020-00001. PMID 16454538.
«Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service». Therapeutic Drug Monitoring 16 (4): 368–74. August 1994. doi:10.1097/00007691-199408000-00006. PMID 7974626.
«Safety evaluation of the concomitant use of clozapine and benzodiazepines: a retrospective, cross-sectional chart review». Journal of Psychiatric Practice 14 (5): 265–70. September 2008. doi:10.1097/01.pra.0000336753.11943.7c. PMID 18832957.
«Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia». European Journal of Clinical Pharmacology 56 (8): 585–9. November 2000. doi:10.1007/s002280000192. PMID 11151749. https://archive.org/details/sim_european-journal-of-clinical-pharmacology_2000-11_56_8/page/585.
«Focus on clozapine». Current Medical Research and Opinion 17 (3): 223–9. 2001. doi:10.1185/0300799039117069. PMID 11900316. https://archive.org/details/sim_current-medical-research-and-opinion_2001_17_3/page/223.
«Evidence that clozapine directly interacts on the GABAB receptor». NeuroReport 22 (13): 637–41. September 2011. doi:10.1097/WNR.0b013e328349739b. PMID 21753741.
«Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice». Journal of Neurochemistry 97 (4): 979–91. May 2006. doi:10.1111/j.1471-4159.2006.03806.x. PMID 16606363.
«The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice». British Journal of Pharmacology 163 (5): 1034–47. July 2011. doi:10.1111/j.1476-5381.2011.01301.x. PMID 21371011.
«Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes». British Journal of Pharmacology 165 (5): 1543–55. March 2012. doi:10.1111/j.1476-5381.2011.01638.x. PMID 21880034.
«Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex». Neuropsychopharmacology 36 (6): 1260–74. May 2011. doi:10.1038/npp.2011.12. PMID 21326193.
DiSanto, Anthony R.; Golden, Gil (2009-08-01). «Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg» (στα αγγλικά). Clinical Drug Investigation 29 (8): 539–549. doi:10.2165/00044011-200929080-00004. ISSN 1179-1918. PMID 19591515.
«Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients». Journal of Clinical Psychopharmacology 24 (1): 70–8. February 2004. doi:10.1097/01.jcp.0000106221.36344.4d. PMID 14709950.
«Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics». The Journal of Clinical Psychiatry 60 (1): 36–40. January 1999. doi:10.4088/JCP.v60n0108. PMID 10074876.
«Letter: Clozapine and agranulocytosis». Lancet 2 (7936): 657. October 1975. doi:10.1016/s0140-6736(75)90135-x. PMID 52022.

pubmedcentral.nih.gov

«Clozapine versus typical neuroleptic medication for schizophrenia». The Cochrane Database of Systematic Reviews (1): CD000059. January 2009. doi:10.1002/14651858.CD000059.pub2. PMID 19160174.
«Clozapine-treated patients have marked gastrointestinal hypomotility, the probable basis of life-threatening gastrointestinal complications: a cross sectional study». EBioMedicine 5: 125–134. March 2016. doi:10.1016/j.ebiom.2016.02.020. PMID 27077119.
«Pharmacological treatment for antipsychotic». The Cochrane Database of Systematic Reviews 1 (1): CD011128. 24 January 2017. doi:10.1002/14651858.CD011128.pub2. PMID 28116777.
Syed, R; Au, K; Cahill, C; Duggan, L; He, Y; Udu, V; Xia, J (16 July 2008). «Pharmacological interventions for clozapine-induced hypersalivation.». The Cochrane Database of Systematic Reviews (3): CD005579. doi:10.1002/14651858.CD005579.pub2. PMID 18646130.
«Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents». Schizophrenia Bulletin 38 (1): 153–166. January 2012. doi:10.1093/schbul/sbq053. PMID 20494946. PMC 3245588. https://archive.org/details/sim_schizophrenia-bulletin_2012-01_38_1/page/153.
«The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice». British Journal of Pharmacology 163 (5): 1034–47. July 2011. doi:10.1111/j.1476-5381.2011.01301.x. PMID 21371011.
«Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes». British Journal of Pharmacology 165 (5): 1543–55. March 2012. doi:10.1111/j.1476-5381.2011.01638.x. PMID 21880034.
«Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex». Neuropsychopharmacology 36 (6): 1260–74. May 2011. doi:10.1038/npp.2011.12. PMID 21326193.

pubchem.ncbi.nlm.nih.gov

«clozapine | C18H19ClN4 – PubChem». pubchem.ncbi.nlm.nih.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Δεκεμβρίου 2013. Ανακτήθηκε στις 16 Ιουλίου 2017.

primarypsychiatry.com

Robinson DS (2007). «CNS Receptor Partial Agonists: A New Approach to Drug Discovery». Primary Psychiatry 14 (8): 22–24. Αρχειοθετήθηκε από το πρωτότυπο στις 18 January 2012. https://web.archive.org/web/20120118091113/http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=1149.

rxlist.com

«RxList Page Not Found». RxList. Αρχειοθετήθηκε από το πρωτότυπο στις 4 Νοεμβρίου 2007. Ανακτήθηκε στις 4 Ιουνίου 2020.

sites.google.com

«Clozapine». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013.
«Clozapine». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013.

sussexpartnership.nhs.uk

Hewitt, Jed· Haste, Jules (Απριλίου 2017). «Protocol for the use of intramuscular (IM) clozapine injection» (PDF). Sussex Partnership NHS Foundation Trust. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 29 Αυγούστου 2021. Ανακτήθηκε στις 15 Μαρτίου 2019.

web.archive.org

«Clozapine». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 1 Δεκεμβρίου 2015.
«Clozapine International Brands». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαρτίου 2017. Ανακτήθηκε στις 28 Φεβρουαρίου 2017.
Hewitt, Jed· Haste, Jules (Απριλίου 2017). «Protocol for the use of intramuscular (IM) clozapine injection» (PDF). Sussex Partnership NHS Foundation Trust. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 29 Αυγούστου 2021. Ανακτήθηκε στις 15 Μαρτίου 2019.
«How would you treat someone who has both schizophrenia and Parkinson's disease?». Αρχειοθετήθηκε από το πρωτότυπο στις 11 Δεκεμβρίου 2013.
«Clozapine». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013.
«Clinical Pharmacology». www.clinicalpharmacology-ip.com. Αρχειοθετήθηκε από το πρωτότυπο στις 28 Αυγούστου 2021. Ανακτήθηκε στις 27 Νοεμβρίου 2020.
«Clozapine». Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2013.
«Clozapine-induced agranulocytosis. Incidence and risk factors in the United States». The New England Journal of Medicine 329 (3): 162–7. July 1993. doi:10.1056/NEJM199307153290303. PMID 8515788. Free full text with registration Αρχειοθετήθηκε 2007-10-20 στο Wayback Machine.
«Treatment of Clozapine-Induced Sialorrhea». Αρχειοθετήθηκε από το πρωτότυπο στις 9 Φεβρουαρίου 2012. Ανακτήθηκε στις 8 Φεβρουαρίου 2010.
«RxList Page Not Found». RxList. Αρχειοθετήθηκε από το πρωτότυπο στις 4 Νοεμβρίου 2007. Ανακτήθηκε στις 4 Ιουνίου 2020.
Robinson DS (2007). «CNS Receptor Partial Agonists: A New Approach to Drug Discovery». Primary Psychiatry 14 (8): 22–24. Αρχειοθετήθηκε από το πρωτότυπο στις 18 January 2012. https://web.archive.org/web/20120118091113/http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=1149.
«clozapine | C18H19ClN4 – PubChem». pubchem.ncbi.nlm.nih.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 24 Δεκεμβρίου 2013. Ανακτήθηκε στις 16 Ιουλίου 2017.
«Supplemental NDA Approval Letter for Clozaril, NDA 19-758 / S-047» (PDF). United States Food and Drug Administration. 18 Δεκεμβρίου 2002. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 8 Νοεμβρίου 2013. Ανακτήθηκε στις 23 Νοεμβρίου 2012.
«Letter to Novartis Pharmaceuticals Corporation» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 11 Μαΐου 2011. Ανακτήθηκε στις 20 Σεπτεμβρίου 2009.

worldcat.org

DiSanto, Anthony R.; Golden, Gil (2009-08-01). «Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg» (στα αγγλικά). Clinical Drug Investigation 29 (8): 539–549. doi:10.2165/00044011-200929080-00004. ISSN 1179-1918. PMID 19591515.